Abstract
The central pathogenic event in prion diseases is the posttranslational conversion of PrPC, a normal cell-surface glycoprotein, into PrPSc, the principal constituent of infectious prion particles (reviewed by Prusiner, 1996). This transformation, which is hypothesized result from a change in the conformation of the polypeptide chain, has been studied both in vivo using transgenic mice (Scott et al., 1996) and in vitro using purified proteins and synthetic peptides (Bessen et al., 1995; Kaneko et al., 1995). The approach we have chosen to take is a cell biological one, focusing on the biosynthesis, posttranslational processing, and cellular trafficking of PrPC and PrPSc in cultured cells (Harris et al., 1996). The techniques we employ include metabolic labeling, immunochemical analysis, microscopy, and subcellular fractionation. The primary advantage of a cell biological approach is the ability to study the formation of PrPSc in the context of the membranes, organelles, and cellular cofactors that are likely to be important in mediating the conversion process.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bessen, R.A., and Marsh, R.F., 1992, Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent, J. Virol. 66: 2096.
Bessen, R.A., Kocisko, D.A., Raymond, G.J., Nandan, S., Landsbury, P.T., and Caughey, B., 1995, Nongenetic propagation of strain-specific properties of scrapie prion protein, Nature 375: 698.
Borchelt, D.R., Taraboulos, A., and Prusiner, S.B., 1992, Evidence for synthesis of scrapie prion proteins in the endocytic pathway, J. Biol. Chem. 267: 16188.
Butler D.A., Scott, M.R.D., Bockman, J.M., Borchelt, D.R., Taraboulos, A., Hsiao, K.K., Kingsbury, D.T., and Prusiner, S.B., 1988, Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins, J. Virol. 62: 1558.
Caughey, B., and Raymond, G.J., 1991, The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-and phospholipase-sensitive, J. Biol Chem. 266: 18217.
Collinge, J., Sidle, K.C., Meads, J., Ironside, J., and Hill, A.F., 1996, Molecular analysis of prion strain variation and the aetiology of “new variant” CJD, Nature 383: 685.
Davitz, M.A., 1988, Use of phenylsepharose to discriminate between hydrophilic and hydrophobic forms of decay accelerating factor, in: Posttranslational Modification of Proteins by Lipids, U. Brodbeck and C. Bordier, eds., Springer-Verlag, Berlin, p. 40.
Deslys, J.-P., Marc J, D., and Dormont, D., 1994, Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease, J. Gen. Virol. 75: 23.
Dlouhy, S.R., Hsiao, K., Farlow, M.R., Foroud, T., Conneally, P.M., Johnson, P., Prusiner, S.B., Hodes, M.E., and Ghetti, B., 1992, Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene, Nature Genet. 1: 64.
Englund, P. T., 1993, The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors, Ann. Rev.Biochem. 62: 121.
Gabizon, R., Telling, G., Meiner, Z., Halimi, M., Kahana, I., and Prusiner, S.B., 1996, Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease, Nature Med. 2: 59.
Goldfarb, L.G., Brown, P., Mitrova, E., Cervenakova, L., Goldin, L., Korczyn, A.D., Chapman, J., Galvez, S., Cartier, L., Rubenstein, R., Gajdusek, D.C., 1991, Creutzfeldt-Jakob disease associated with the PRNP codon 200LYS mutation: an analysis of 45 families, Eur. J. Epidem. 7: 471.
Goldfarb, L.G., Petersen, R.B., Tabaton, M., Brown, P., LeBlanc, A.C., Montagna, P., Cortelli, P., Julien, J., Vital, C., Pendelbury, W.W., Haltia, M., Wills, P.R., Hauw, J.J., McKeever, P.E., Monari, L., Schrank, B., Swergold, G.D., Autilio-Gambetti, L., Gajdusek, D.C., Lugaresi, E., and Gambetti, P., 1992, Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism, Science 258: 806.
Harris, D.A., 1997, Cell biological insights into prion diseases, in: Prion Diseases: Current State and Perspectives in Prion Research, H. Kretzschmar, and D. Riesner, eds., Chapman and Hall, New York, In Press.
Harris, D.A., Gorodinsky, A., Lehmann, S., Moulder, K., and Shyng, S.-L., 1996, Cell biology of the prion protein, Curr. Topics in Microbiol. and Immunol. 207: 79.
Hsiao, K., Baker H.F., Crow, T.J., Poulter, M., Owen, F., Terwilliger, J.D., Westaway, D., Ott, J., and Prusiner, S.B., 1989, Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome, Nature 338: 342.
Hsiao, K., Meiner, Z., Kahana, E., Cass, C, Kahana, I., Avrahami, D., Scarlato, G., Abramsky, O., Prusiner, S.B., Gabizon, R., 1991, Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease, N Engl. J. Med. 324: 1091.
Hsiao, K., Dlouhy, S.R., Farlow, M.R., Cass, C., Da Costa, M., Conneally, P.M., Hodes, M.E., Ghetti, B., and Prusiner, S.B., 1992, Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles, Nature Genet. 1: 68.
Kaneko, K., Peretz, D., Pan, K.-M., Blochberger, T.C., Wille, H., Gabizon, R., Griffith, O.H., Cohen, F.E., Baldwin, M.A., and Prusiner, S.B., 1995, Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform, Proc. Natl. Acad. Sci. USA 92: 11160.
Lehmann, S., and Harris, D.A., 1995, A mutant prion protein displays an aberrant membrane association when expressed in cultured cells, J. Biol. Chem. 270: 24589.
Lehmann, S., and Harris, D.A., 1996a, Mutant and infectious prion proteins display common biochemical properties in cultured cells. J. Biol.Chem. 271: 1633.
Lehmann, S., and Harris, D.A., 1996b, Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform, Proc. Natl. Acad. Sci. USA 93: 5610.
Meiner, Z., Halimi, M., Polakiewicz, R.D., Prusiner, S.B., and Gabizon R., 1992, Presence of prion protein in peripheral tissues of Libyan Jews with Creutzfeldt-Jakob disease, Neurol. 42: 1355.
Monari, L., Chen, S.G., Brown, P., Parchi, P., Petersen, R.B., Mikol, J., Gray, F., Cortelli, P., Montagna, P., Ghetti, B., Goldfarb, L., Gajdusek, D.C., Lugaresi, E., Gambetti, P., Autilio-Gambetti, L., 1994, Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism, Proc. Natl. Acad. Sci. USA 91: 2839.
Owen, F., Poulter, M., Collinge, J., and Crow, T.J., 1990, Codon 129 changes in the prion protein gene in Caucasians, Am. J. Hum. Genet. 46: 1215.
Palmer, M.S., Dryden, A.J., Hughes, J.T., and Collinge, J., 1991, Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease, Nature 352: 340.
Parchi, P., Castellani, R., Capellari, S., Ghetti, B., Young, K., Chen, S.G., Farlow, M., Dickson, D.W., Sima, A.A.F., Trojanowski, J.Q., Petersen, R.B., and Gambetti, P., 1996, Molecular basis of phenotype variability in sporadic Creutzfeldt-Jakob disease, Ann. Neurol. 39: 767.
Poulter, M., Baker, H.F., Frith, C.D., Leach, M., Lofthouse, R., Ridley, R.M., Shah, T., Owen, F., Collinge, J., Brown, J., Hardy, J., Mullan, M.J., Harding, A.E., Bennett, C., Doshi, R., Crow, T.J., 1992, Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain 115: 675.
Prusiner, S.B., 1996, Prions, in: Virology, 3rd Edition, B.N. Fields, D.M. Knipe, and P.M. Howley, eds., Lipincott-Raven Press, Philadelphia, p. 2901.
Prusiner, S.B., and Hsiao, K.K., 1994, Human prion diseases, Ann. Neurol. 35: 385.
Race, R.E., Caughey, B., Graham, K., Ernst, D., and Chesebro, B., 1988, Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones, J. Virol. 62: 2845.
Rubinstein, R., Deng, H., Scalici, C.L., and Papini, C, 1991, Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells, J. Gen. Virol. 72: 1279.
Scott, M.R.D., Telling, G.C., and Prusiner, S.B., 1996, Transgenetics and gene targeting in studies of prion diseases, Curr. Top. Microbiol Immunol. 207: 95.
Stahl, N., Borchelt, D.R., Hsiao, K., and Prusiner, S.B., 1987, Scrapie prion protein contains a phosphatidylinositol glycolipid anchor, Cell 51: 229.
Tagliavini, F., Prelli, F., Porro, M., Rossi, G., Fiaccone, G., Farlow, M.R., Dlouhy, S.R., Ghetti, B., Bugiani, O., and Fragione, B., 1994, Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana kindreds) express only PrP peptides encoded by the mutant allele, Cell 79: 695.
Taraboulos, A., Serban, D., and Prusiner, S.B., 1990, Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells, J. Cell Biol. 110: 2117.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Harris, D.A., Lehmann, S., Daude, N. (1998). Familial Prion Diseases Modeled in Cell Culture. In: Morrison, D.R.O. (eds) Prions and Brain Diseases in Animals and Humans. NATO ASI Series, vol 295. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1896-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1896-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1898-7
Online ISBN: 978-1-4899-1896-3
eBook Packages: Springer Book Archive